AI-driven microbiome science for precision health interventions
We integrate multiple cutting-edge technologies to accelerate discovery and ensure evidence-based product development:
Predictive models for strain efficacy, drug-microbiome interactions, and personalized interventions
Combining genomics, metabolomics, and clinical data for comprehensive understanding
Semantic networks connecting strains, metabolites, diseases, and outcomes for intelligent reasoning
In silico prediction of intervention outcomes to accelerate development and reduce costs
Our artificial intelligence platform analyzes vast datasets of microbial genomes, metabolic pathways, clinical outcomes, and population health data to identify optimal probiotic strains for specific conditions. Machine learning models predict strain efficacy, safety profiles, and synergistic combinations, enabling data-driven formulation design that goes beyond traditional trial-and-error approaches.
Our bioinformatics pipeline processes microbiome sequencing data, metabolomic profiles, and clinical parameters to create comprehensive health signatures. We use cutting-edge algorithms for taxonomic classification, functional annotation, and pathway analysis, enabling precise characterization of gut microbiome composition and function.
At the heart of our platform is a comprehensive, open-access microbiome knowledge graph that connects microbial strains, metabolic pathways, nutrients, bioactive compounds, disease states, health outcomes, traditional fermented foods, and clinical trial data. This semantic network enables intelligent reasoning about complex relationships between gut microbiome composition and health.
We employ advanced computational models to simulate microbiome dynamics, predict intervention outcomes, and optimize formulation parameters. Our in silico models reduce the need for extensive wet-lab experimentation, accelerating product development while ensuring scientific rigor.
Integrated workflow from data collection to validated clinical solutions
Microbiome samples, health records, and clinical outcomes
Bioinformatics and knowledge graph integration
Machine learning models predict optimal strains
Strain isolation, testing, and formulation development
Validation through rigorous clinical studies
GMP production and quality control
Unlike generic probiotics, we design formulations for specific conditions (cancer, TB, diabetes) with scientifically validated strains that produce therapeutic metabolites.
Our formulations account for genetic backgrounds, dietary patterns, and cultural practices specific to Indian populations, ensuring higher efficacy and acceptability.
Our platform improves through real-world feedback, continuously refining strain selection and formulation strategies based on outcomes data.
We leverage India's rich fermentation traditions, fortifying culturally familiar foods with scientifically optimized strains for maximum acceptance and impact.
© 2026 Leeuwenhoek Biocorporation. All rights reserved.